Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPERA-T
2024-511281-36-00Phase 3Completed
- Sponsor
- Pulmocide
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 20
01
Overview
Phase 3, randomised, double-blind trial in Acute Invasive Aspergillosis comparing Opelconazole arm with Placebo arm (2 arms). Primary endpoint: Number of participants with complete or partial overall response. Started Dec 2024; status: completed.
02
Drugs
opelconazole
03
Conditions
Acute Invasive Aspergillosis
Beyond the preview
Go deeper on 2024-511281-36-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511281-36-00.